Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Auto Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03685786
What this trial is testing

CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute, B-CellLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell
Shenzhen Second People's Hospital 20
Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Large-scale testing (Phase 3)UnknownNCT02842931
What this trial is testing

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Who this might be right for
Diffuse Large B-Cell Lymphoma
National Research Center for Hematology, Russia 300
Not applicableStudy completedNCT01852591
What this trial is testing

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02269150
What this trial is testing

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell
Memorial Sloan Kettering Cancer Center 59
Large-scale testing (Phase 3)UnknownNCT03695055
What this trial is testing

Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma

Who this might be right for
High-risk Aggressive Lymphoma After Auto-HSCT
Fujian Medical University 60
Testing effectiveness (Phase 2)UnknownNCT03795597
What this trial is testing

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Loyola University 36
Testing effectiveness (Phase 2)Ended earlyNCT01453088
What this trial is testing

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 63
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Large-scale testing (Phase 3)Study completedNCT00114530
What this trial is testing

Scleroderma: Cyclophosphamide or Transplantation

Who this might be right for
Scleroderma, SystemicSclerosisAutoimmune Disease
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT03317899
What this trial is testing

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaPlasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06597513
What this trial is testing

Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 10
Testing effectiveness (Phase 2)UnknownNCT05493800
What this trial is testing

Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT

Who this might be right for
Oral MucositisLymphomaMultiple Myeloma+1 more
MitoImmune Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT07236151
What this trial is testing

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

Who this might be right for
Large B-cell LymphomaCAR T Cell TherapyAuto Stem Cell Transplant
The First Affiliated Hospital of Soochow University 23
Post-approval studies (Phase 4)UnknownNCT03707847
What this trial is testing

Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL

Who this might be right for
ALK-Positive Anaplastic Large Cell Lymphoma
Mingzhi Zhang 20
Testing effectiveness (Phase 2)Ended earlyNCT01468311
What this trial is testing

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Who this might be right for
Hodgkin DiseaseHodgkin Lymphoma
National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03948035
What this trial is testing

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Wuerzburg University Hospital 576
Not applicableStudy completedNCT06755333
What this trial is testing

Oral Hygiene Management of Hematologic Patients Undergoing Auto-transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
University of Pisa 35
Testing effectiveness (Phase 2)Looking for participantsNCT06608342
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Next Page